Previous 10 | Next 10 |
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2021 Q2 earnings call. For further details see: Integra LifeSciences Holdings Corporation 2021 Q2 - Results - Earnings Call Presentation
Integra LifeSciences Holdings Corporation (IART) Q2 2021 Results Conference Call July 28, 2021 08:30 AM ET Company Participants Mike Beaulieu - Head of Investor Relations Peter Arduini - President and Chief Executive Officer Glenn Coleman - Chief Operating Officer Carrie Anderson - Chief Fina...
Image source: The Motley Fool. Integra LifeSciences Holdings Corporation (NASDAQ: IART) Q2 2021 Earnings Call Jul 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Integra LifeSciences Holdings Corporation (IART) ...
Although the medical devices industry faced unprecedented challenges presented by the COVID-19 pandemic last year, it has bounced back this year thanks to increasing immunization rates. A recovery in demand for elective and essential surgical procedures, and rapid innovations, have bolstered ...
Integra LifeSciences Holdings (IART): Q2 Non-GAAP EPS of $0.79 beats by $0.13; GAAP EPS of $0.41 beats by $0.08.Revenue of $390M (+50.8% Y/Y) beats by $13.72M.Press Release For further details see: Integra LifeSciences Holdings EPS beats by $0.13, beats on revenue
Second Quarter 2021 Highlights Revenues of $390.0 million increased 50.8% on a reported basis and 48.7% on an organic basis compared to the prior year; GAAP earnings per diluted share of $0.41, compared to $(0.00) in the second quarter of 2020; adjusted earnings per diluted ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Integra LifeSciences (IART) announces positive results from the study of PriMatrix Dermal Repair Scaffold for the management of hard to heal diabetic foot ulcers ((DFUs)).Results showed that application of PriMatrix plus standard of care ((SOC)) healed 60% of DFUs in 12 weeks versus...
PRINCETON, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical outcomes for PriMatrix® Dermal Repair Scaffold for the management of hard to heal diabe...
News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
Integra LifeSciences Holdings Corporation Website:
2024-07-30 13:15:02 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for IART on July 30, 2024 11:36AM ET. The previous analyst recommendation was Market Outperform. IART was trading at $24.945 at issue of the analyst recommendation. The overall analyst ...
2024-07-30 10:00:08 ET Richard Newitter from Truist Financial issued a price target of $26.00 for IART on 2024-07-30 08:59:00. The adjusted price target was set to $26.00. At the time of the announcement, IART was trading at $24.59. The overall price target consensus is ...
2024-07-30 06:30:09 ET Citigroup analyst issues SELL recommendation for IART on July 30, 2024 03:24AM ET. The previous analyst recommendation was Neutral. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current...